Review Article
Microtubule Organization Is Essential for Maintaining Cellular Morphology and Function
Table 1
Summary of various MT-targeting agents applied to protect the nervous system.
| Classification | Compound | Pathological model | Outcome | Ref. |
| MSAs | Paclitaxel (Taxol) | SCI | Enhancement of nerve regeneration and functional recovery | [119, 120] | Retinal nerve injury | Increased MT numbers and stabilization to restore axonal transport | [121] | AD | Improvements in axonal transport, tissue, and motor function | [122] | Epothilones | SCI | Decreased scarring, increased axon regeneration, and improved motor function | [102, 103] | PD | Rescued MT defects and attenuated nigrostriatal degeneration | [123] | AD | Reduced axonal dystrophy, increased axonal MT density, improved speed of axonal transport, and improved cognitive performance | [124, 125] | Davunetide (NAP) | AD, ALS | Prevented axonal transport disruption, synaptic defects, and behavioral impairments | [126, 127] |
| MDAs | Vincristine | iPSC-derived neurons from HSP patients | Ameliorated axonal swelling | [128] | Okadaic acid | Hyperphosphorylated Tau to model AD | Reduced the growth of the rat cortical neuron axons | [129] |
|
|